Bob Maguire, MBA, CEO
Bob has decades of proven business acumen and success with his focus on Axolotl's growth and revenue goals.
Previously, Bob has held senior leadership roles as the VP of Sales for a software company, as CEO of a marketing and distribution company that sold amniotic stem cell fluid and autologous stem cell kits to medical practices; and as President and CEO of Advanced Telemanagement Group, Inc., a company that he founded in January of 1995. Bob has also held other leadership positions at companies like ADP, PAETEC, and AT&T.
Bob earned a bachelor of arts in communications and business from Manhattan College while playing varsity basketball for the Jaspers. He also earned his Executive MBA from the W.P. Carey School of Business at Arizona State University in 2013, where the faculty and staff awarded him the annual W.P. Carey School of Business Leadership Award.
Phillip Larson, President
Phillip will keep Axolotl in the spotlight and on the cutting edge in his role as President through his knowledge and experience within the fields of business and medicine.
Phillip has a unique understanding of both business and medicine, which affords him the ability to see opportunities in commerce and research. In December of 2012 he graduated with honors from Arizona State University where he studied business and life sciences (Biomedical Engineering).
He went on to attend Midwestern University for cardiovascular perfusion and completed all of his didactics. While attending Midwestern he realized that he had a greater passion for enterprise and regenerative medicine.
Robert S. Kellar, Ph.D., Chief Science Officer
Dr. Robert Kellar is the Chief Science Officer for Axolotl Biologix. He has over 16 years of experience in the development and regulatory approval of medical devices, cell-based products, and regenerative medicine and tissue-engineered technology. He has 29 peer-reviewed publications and 2 issued US patents. He received his PhD from the University of Arizona in 2001.
Dr. Kellar currently serves on the Scientific Advisory Board for MyoStim, and is on the Faculty in the Center for Bioengineering Innovation (CBI), Biological Sciences and Mechanical Engineering at Northern Arizona University. Dr. Kellar has helped to co-found a number of companies including Development Engineering Sciences, a biomedical consulting firm, Flagship Biosciences, a digital pathology company, and Autogenesis Corporation, a wound healing company. He serves as an Advisory Board Member for Protein Genomics, a protein polymer medical device company, and the California Stock Exchange.
Dr. Kellar’s previous roles include: VP of Research and Development at Histogen, Inc. in San Diego, CA, Product Specialist at W.L. Gore and Associates in Flagstaff, AZ, and Lead Scientist and Project Manager at Advanced Tissue Sciences, Inc. in La Jolla, CA.
Dr. Terry Bagley, Medical Director
Dr. Bagley graduated from Utah State University in 1987 and the Medical College of Wisconsin in 1992. Dr. Bagley completed an internship in Internal Medicine before his residency training in Physical Medicine and Rehabilitation at Walter Reed Army Medical Center in Washington D.C. After residency, Dr. Bagley served four years as staff physician at William Beaumont Army Medical Center in El Paso, Texas before entering into private practice.
Dr. Bagley's special interest is the non-operative treatment of musculoskeletal pain, including acute and chronic spine, joint, tendon, and trigger points. Dr. Bagley was also trained in acupuncture at UCLA for the treatment of chronic pain and fibromyalgia. He also performs electro-diagnostic studies (EMG/NCS's) to diagnose muscle and nerve disorders and is a staff physician at Mountain Valley Regional Rehabilitation Hospital.
Eric Lee, Director of Research and Education
Eric graduated from Case Western University in May 2010 with a degree in Biomedical Engineering. Afterwards he worked at MedVoxel, a Vancouver, British Columbia company, which developed web-based tools for cardiac MRI processing. Eric was responsible for FDA documentation, testing, and communicating with physicians, software developers, and engineers to collect feedback used to apply productively to the development cycle. In 2013, Eric worked as a high school science and math tutor at ThinkTank Learning, while he applied to graduate schools across the nation. Eric was accepted into the Johns Hopkins University's graduate program for Masters in Science in Applied Biomedical Engineering. Eric's role at Axolotl will be to assist in the research and development of marketable products and to use his teaching experience to educate doctors on procedures for using the products that Axolotl will develop.
Jon Canyon, Director of Partnerships
Jon is focused on building partnerships for doing research through understanding and acceptance of the potential impact that regenerative medicine can have on an individual's quality of life. Jon studied cell biology at Arizona State University.
Andrew Vo, Quality Assurance Analyst
Andrew graduated from Arizona State University with a bachelor's degree in Biochemistry. He has worked at several different companies as a lab technician and as a quality-control consultant. His role at Axolotl is helping to develop effective laboratory practices and documentation systems, ensuring that the company is compliant with the standards of the FDA other regulatory agencies.